Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer.

Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer.
复制标题

DOI:
10.1016/j.omto.2021.04.004
复制
发表时间:
2021-06-25
期刊:
Molecular therapy oncolytics
影响因子:
--
通讯作者:
Green JJ
Green JJ
中科院分区:
其他
文献类型:
--
作者:
Vaughan HJ;Zamboni CG;Radant NP;Bhardwaj P;Revai Lechtich E;Hassan LF;Shah K;Green JJ

文献摘要

参考文献

相似文献

Despite initial promise, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based approaches to cancer treatment have yet to yield a clinically approved therapy, due to delivery challenges, a lack of potency, and drug resistance. To address these challenges, we have developed poly(beta-amino ester) (PBAE) nanoparticles (NPs), as well as an engineered cDNA sequence encoding a secretable TRAIL (sTRAIL) protein, to enable reprogramming of liver cancer cells to locally secrete TRAIL protein. We show that sTRAIL initiates apoptosis in transfected cells and has a bystander effect to non-transfected cells. To address TRAIL resistance, NP treatment is combined with histone deacetylase inhibitors, resulting in >80% TRAIL-mediated cell death in target cancer cells and significantly slowed xenograft tumor growth. This anti-cancer effect is specific to liver cancer cells, with up to 40-fold higher cell death in HepG2 cancer cells over human hepatocytes. By combining cancer-specific TRAIL NPs with small-molecule-sensitizing drugs, this strategy addresses multiple challenges associated with TRAIL therapy and offers a new potential approach for cancer treatment. Green and colleagues develop polymeric nanoparticles to program liver cancer cells to locally secrete tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL). The authors show that the delivered sTRAIL initiates apoptosis in transfected liver cancer cells and has a bystander effect to non-transfected cancer cells, with potency enhanced by histone deacetylase inhibitors.
DOI: 10.1007/s12015-016-9670-8
发表时间: 2016-10
影响因子: 4.8
作者:
Ansari, Amir Mehdi;Ahmed, A. Karim;Matsangos, Aerielle E.;Lay, Frank;Born, Louis J.;Marti, Guy;Harmon, John W.;Sun, Zhaoli
通讯作者: Sun, Zhaoli
DOI: 10.1038/onc.2012.164
发表时间: 2013-03-14
期刊: Oncogene
影响因子: 8
作者:
Dimberg LY;Anderson CK;Camidge R;Behbakht K;Thorburn A;Ford HL
通讯作者: Ford HL
DOI: 10.1021/nn501197v
发表时间: 2014-05-27
期刊: ACS NANO
影响因子: 17.1
作者:
Guerrero-Cazares, Hugo;Tzeng, Stephany Y.;Young, Noah P.;Abutaleb, Ameer O.;Quinones-Hinojosa, Alfredo;Green, Jordan J.
通讯作者: Green, Jordan J.
DOI: 10.1016/j.biomaterials.2010.07.023
发表时间: 2010-11
期刊: BIOMATERIALS
影响因子: 14
作者:
Bhise, Nupura S.;Gray, Ryan S.;Sunshine, Joel C.;Htet, Soe;Ewald, Andrew J.;Green, Jordan J.
通讯作者: Green, Jordan J.
DOI: 10.1016/s1535-6108(04)00058-3
发表时间: 2004-03-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Bruix, J;Boix, L;Llovet, JM
通讯作者: Llovet, JM